Studies on the interaction between promethazine and human serum albumin in the presence of flavonoids by spectroscopic and molecular modeling techniques

Colloids and Surfaces B: Biointerfaces

Volumn 145, Issue , 2016, Pages 820-829

  He, Ling Ling ^a   Wang, Zhi Xin ^a   Wang, Yong Xia ^a   Liu, Xian Ping ^a   Yang, Yan Jie ^a   Gao, Yan Ping ^a   Liu, Bin ^b   Wang, Xin ^b  

^a SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b LIAONING UNIVERSITY   (China)

Author keywords

Competitive binding; Flavonoids; Food drug interaction; Human serum albumin; Promethazine

Indexed keywords

ABSORPTION SPECTROSCOPY; AMINO ACIDS; BINDING ENERGY; BODY FLUIDS; DICHROISM; DRUG INTERACTIONS; ENERGY TRANSFER; FLAVONOIDS; FLUORESCENCE QUENCHING; HYDROGEN BONDS; HYDROPHOBICITY; MOLECULAR MODELING; PARTICLE BEAMS;

COMPETITIVE BINDING; FLUORESCENCE QUENCHING MECHANISM; HUMAN SERUM ALBUMINS; HYDROPHOBIC INTERACTIONS; MOLECULAR MODELING TECHNIQUES; PROMETHAZINE; SPECTROSCOPIC TECHNIQUE; TIME-CORRELATED SINGLE-PHOTON COUNTING;

BINDING SITES;

BAICALIN; HUMAN SERUM ALBUMIN; IBUPROFEN; PROMETHAZINE; RUTOSIDE; TRYPTOPHAN; WARFARIN; FLAVONOID; PROTEIN BINDING; SERUM ALBUMIN;

ABSORPTION; ARTICLE; ASSOCIATION CONSTANT; BINDING AFFINITY; BINDING COMPETITION; BINDING DISTANCE; BINDING SITE; CHEMICAL PARAMETERS; CHEMICAL PHENOMENA; CHEMICAL PROCEDURES; CIRCULAR DICHROISM; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG POTENTIATION; DRUG PROTEIN BINDING; ENERGY TRANSFER; FLUORESCENCE; FLUORESCENCE QUENCHING; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR MODEL; PRIORITY JOURNAL; TIME CORRELATED SINGLE PHOTON COUNTING; CHEMISTRY; HUMAN;

CIRCULAR DICHROISM; FLAVONOIDS; HUMANS; PROMETHAZINE; PROTEIN BINDING; RUTIN; SERUM ALBUMIN;

EID: 84973868046     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.06.001     Document Type: Article

References (73)

1. Lempers V.J.C., Martial L.C., Schreuder M.F., Blijlevens N.M., Burger D.M., Aarnoutse R.E., Brüggemann R.J.M. Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice. Curr. Opin. Pharmacol. 2015, 24:38-44.
2. Fasinu P.S., Bouic P.J., Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions. Front. Pharmacol. 2012, 3:69.
3. Khan A.B., Khan J.M., Ali M.S., Khan R.H., Kabir-ud-Din Interaction of amphiphilic drugs with human and bovine serum albumins. Spectrochim. Acta Part A 2012, 97:119-124.
4. Ishtikhar M., Rabbani G., Khan R.H. Interaction of 5-fluoro-5'-deoxyuridine with human serum albuminunder physiological and non-physiological condition: a biophysical investigation. Colloid Surf. B 2014, 123:469-477.
5. Poór M., Li Y., Kunsági-Máté S., Petrik J., Vladimir-Knežević S., Koszegi T. Molecular displacement of warfarin from human serum albumin by flavonoid aglycones. J. Lumin 2013, 142:122-127.
6. Sattar Z., Iranfar H., Asoodeh A., Saberi M.R., Mazhari M., Chamani J. Interaction between holo transferring and HSA-PPIX complex in the presence of lomefloxacin: an evaluation of PPIX aggregation in protein-protein interactions. Spectrochim. Acta A 2012, 97:1089-1100.
7. Varshney A., Rehan M., Subbarao N., Rabbani G., Khan R.H. Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug binding. PLoS One 2011, 6:e17230.
8. 3+ ion. Food Res. Int. 2011, 44:2861-2867.
9. Omidvar Z., Parivar K., Sanee H., Amiri-Tehranizadeh Z., Baratian A., Saberi M.R., Asoodeh A., Chamani J. Investigations with spectroscopy, zeta potential and molecular modeling of the non-cooperative behaviour between cyclophosphamide hydrochloride and aspirin upon interaction with human serum albumin: binary and ternary systems from multi-drug therapy. J. Biomol. Struct. Dyn. 2011, 29:181-206.
10. Shi S., Zhang Y., Xiang X., Huang K., Chen X., Peng M. The influence of flavonoids on the binding of pantoprazole to bovine serum albumin by spectroscopic methods: with the viewpoint of food/drug interference. Food Chem. 2012, 135:1083-1090.
11. Strenkoski-Nix L.C., Ermer J., DeCleene S., Cevallos W., Mayer P.R. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects. Am. J. Health Syst. Pharm. 2000, 57:1499-1505.
12. Paton D.M., Webster D.R. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clin. Pharmacokinet. 1985, 10:477-497.
13. 2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis. Psychopharmacology (Berl) 1995, 121:347-356.
14. 2 receptor binding sites for agonists. A tetrahedral model. Mol. Pharmacol. 1985, 28:391-399.
15. Bulloch M.N., Engelbrecht J.D., Wheat J. Drug-induced delirium from a suspected drug-drug interaction between promethazine and ketorolac. Int. J. Clin. Pharmacol. Toxicol. 2012, 1:32-34.
16. Rukhadze M.D., Alexishvili M.M., Gonashvili M.V., Okujava N.V., Sebiskveradze M.V. Interaction of carbamazepine and promethazine in rabbits. Biomed. Chromatogr. 2003, 17:62-69.
17. Rukhadze M.D., Alexishvili M.M., Gonashvili M.V., Sebiskveradze M.V. Interaction of surface active drugs in rabbits. Biomed. Chromatogr. 2005, 19:123-128.
18. Kokiashvili N., Alexishvili M., Gonashvili M., Okujava N., Titvinidze G., Rukhadze M. Revealing of pharmacokinetic peculiarities of surface active drug promethazine in its interaction with caffeine in rabbits. Colloid Surf. A 2012, 413:169-173.
19. Sankari S.L., Babu N.A., Rani V., Priyadharsini C., Masthan K.M. Flavonoids-clinical effects and applications in dentistry: a review. J. Pharm. Bioallied. Sci. 2014, 6(Suppl 1):S26-S29.
20. Gupta N., Chauhan R.S., Pradhan J.K. Rutin: a bioactive flavonoid. Handbook of Medicinal Plants and Their Bioactive Compounds 2014, 51-57. Research Signpost, Kerala, India. N. Gupta (Ed.).
21. Lilamand M., Kelaiditi E., Guyonnet S., Antonelli Incalzi R., Raynaud-Simon A., Vellas B., Cesari M. Flavonoids and arterial stiffness: promising perspectives. Nutr. Metab. Cardiovasc. Dis. 2014, 24:698-704.
22. Feliciano R.P., Pritzel S., Heiss C., Rodriguez-Mateos A. Flavonoid intake and cardiovascular disease risk. Curr. Opin. Food Sci. 2015, 2:92-99.
23. Testai L. Flavonoids and mitochondrial pharmacology: a new paradigm for cardioprotection. Life Sci. 2015, 135:68-76.
24. Karabin M., Hudcova T., Jelinek L., Dostalek P. Biotransformations and biological activities of hop flavonoids. Biotechnol. Adv. 2015, 33:1063-1090.
25. Xiao J., Muzashvili T.S., Georgiev M.I. Advances in the biotechnological glycosylation of valuable flavonoids. Biotechnol. Adv. 2014, 32:1145-1156.
26. Kozłowska A., Szostak-Wegierek D. Flavonoids-food sources and health benefits. Rocz. Panstw. Zakl. Hig. 2014, 65:79-85.
27. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:S2073-S2085.
28. Mohseni-Shahri F.S., Housaindokht M.R., Bozorgmehr M.R., Moosavi-Movahedi A.A. The influence of the flavonoid quercetin on the interaction of propranolol with human serum albumin: experimental and theoretical approaches. J. Lumin. 2014, 154:229-240.
29. Wang X., Liu Y., He L.L., Liu B., Zhang S.Y., Ye X., Jing J.J., Zhang J.F., Gao M., Wang X. Spectroscopic investigation on the food components-drug interaction: the influence of flavonoids on the affinity of nifedipine to human serum albumin. Food Chem. Toxicol. 2015, 78:42-51.
30. Zhang Y., Shi S., Chen X., Zhang W., Huang K., Peng M. Investigation on the interaction between ilaprazole and bovine serum albumin without or with different C-ring flavonoids from the viewpoint of food_drug interference. J. Agric. Food Chem. 2011, 59:8499-8506.
31. Ajay A., Deepak D., Anjali N., Jitesh K. Protein binding: a study of interaction between diclofenac sodium and bovine serum albumin. Asian J. Pharm. Res. Dev. 2013, 1:98-102.
32. Rahnama E., Mahmoodian-Moghaddam M., Khorsand-Ahmadi S., Saberi M.R., Chamani J. Binding site identification of metformin to human serum albumin and glycated human serum albumin by spectroscopic and molecular modeling techniques: a comparison study. J. Biomol. Struct. Dyn. 2015, 33:513-533.
33. Iranfar H., Rajabi O., Salari R., Chamani J. Probing the interaction of human serum albumin with ciprofloxacin in the presence of silver nanoparticles of three sizes: multispectroscopic and ζ potential investigation. J. Phys. Chem. B 2012, 116:1951-1964.
34. Tabassum S., Al-Asbahy W.M., Afzal M., Arjmand F., Khan R.H. Interaction and photo-induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and molecular docking study. Mol. Biosyst. 2012, 8:2424-2433.
35. Shyamali S.S., Lillian D.R., Lawrence L., Esther B. Fluorescence studies of native and modified neurophysins. Effects of peptides and pH. Biochemistry 1979, 18:1026-1036.
36. Peng X., Wang X., Qi W., Huang R., Su R., He Z. Deciphering the binding patterns and conformation changes upon the bovine serum albumin-rosmarinic acid complex. Food Funct. 2015, 6:2712-2726.
37. Petitpas I., Gruene T., Bhattacharya A.A., Curry S. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 2001, 314:955-960.
38. Varshney A., Ansari Y., Zaidi N., Ahmad E., Badr G., Alam P., Khan R.H. Analysis of binding interaction between antibacterial ciprofloxacin and human serum albumin by spectroscopic techniques. Cell Biochem. Biophys. 2014, 70:93-101.
39. Sudhamalla B., Gokara M., Ahalawat N., Amooru D.G., Subramanyam R. Molecular dynamics simulation and binding studies of β-sitosterol with human serum albumin and its biological relevance. J. Phys. Chem. B 2010, 114:9054-9062.
40. Sattar Z., Saberi M.R., Chamani J. Determination of LMF binding site on a HSA-PPIX complex in the presence of human holo transferrin from the viewpoint of drug loading on proteins. PLoS One 2014, 9:e84045.
41. Kabiri M., Amiri-Tehranizadeh Z., Baratian A., Saberi M.R., Chamani J. Use of spectroscopic, zeta potential and molecular dynamic techniques to study the interaction between human holo-transferrin and two antagonist drugs: comparison of binary and ternary systems. Molecules 2012, 17:3114-3147.
42. Rub M.A., Khan J.M., Asiri A.M., Khan R.H., Kabir-ud-Din Study on the interaction between amphiphilic drug and bovine serum albumin: a thermodynamic and spectroscopic description. J. Lumin. 2014, 155:39-46.
43. Mansouri M., Pirouzi M., Saberi M.R., Ghaderabad M., Chamani J. Investigation on the interaction between cyclophosphamide and lysozyme in the presence of three different kind of cyclodextrins: determination of the binding mechanism by spectroscopic and molecular modeling techniques. Molecules 2013, 18:789-813.
44. Lakowicz J.R. Principles of Fluorescence Spectroscopy 2006, Springer Science + Business Media, New York. third ed.
45. Lakowicz J.R., Weber G. Quenching of protein fluorescence by oxygen: detection of structural fluctuations in proteins on the nanosecond time scale. Biochemistry 1973, 12:4171-4179.
46. Ware W.R. Oxygen quenching of fluorescence in solution: an experimental study of the diffusion process. J. Phys. Chem. 1962, 66:445-458.
47. Lehrer S.S. Solute perturbation of protein fluorescence. Quenching of the tryptophyl fluorescence of model compoundsand of lysozyme by iodide ion. Bioehemistry 1971, 10:3254-3263.
48. Ahmad E., Rabbani G., Zaidi N., Khan M.A., Qadeer A., Ishtikhar M., Singh S., Khan R.H. Revisiting ligand-induced conformational changes in proteins: essence, advancements, implications and future challenges. J. Biomol. Struct. Dyn. 2013, 31:630-648.
49. Ross P.D., Subramanian S. Thermodynamics of protein association reaction: forces contribution to stability. Biochemistry 1981, 20:3096-3102.
50. Carter D.C., Ho J.X. Structure of serum albumin. Adv. Prot. Chem. 1994, 45:153-203.
51. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 1992, 358:209-215.
52. Suldlow G., Birkett D.J., Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 1975, 11:824-832.
53. Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S. Crystal structure analysis of warfarin binding to human serum albumin. J. Biol. Chem. 2001, 276:22804-22809.
54. Sudlow G., Birkett D.J., Wade D.N. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 1976, 12:1052-1061.
55. Pastukhov A.V., Levchenko L.A., Sadkov A.P. Spectroscopic study on binding of rutin to human serum albumin. J. Mol. Struct. 2007, 842:60-66.
56. Liu C.H., Li Y.Q., Jia B.X., Qi Y.X., Li K. Study on interaction between baicalin and human serum albumin. J. Instrument. Anal. 2011, 30:532-536. (in Chinese).
57. Sheng F., Wang Y., Zhao X., Tian N., Hu H., Li P. Separation and identification of anthocyanin extracted from mulberry fruit and the pigment binding properties toward human serum albumin. J. Agric. Food Chem. 2014, 62:6813-6819.
58. Förster T. Delocalized excitation and excitation transfer. Modern Quantum Chemistry 1996, 93-137. Academic Press, New York. O. Sinanoglu (Ed.).
59. Mohammadi F., Bordbar A.K., Divsalar A., Mohammadi K., Saboury A.A. Analysis of binding interaction of curcumin and diacetylcurcumin with human and bovine serum albumin using fluorescence and circular dichroism spectroscopy. Protein J. 2009, 28:189-196.
60. Chaturvedi S.K., Ahmad E., Khan J.M., Alam P., Ishtikhar M., Khan R.H. Elucidating the interaction of limonene with bovine serum albumin: a multi-technique approach. Mol. BioSyst. 2015, 11:307-316.
61. Pace C.N., Vajdos F., Fee L., Grimsley G., Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 1995, 4:2411-2423.
62. Azimi O., Emami Z., Salari H., Chamani J. Probing the interaction of human serum albumin with norfloxacin in the presence of high-frequency electromagnetic fields: fluorescence spectroscopy and circular dichroism investigations. Molecules 2011, 16:9792-9818.
63. Shu Y., Xue W., Xu X., Jia Z., Yao X., Liu S., Liu L. Interaction of erucic acid with bovine serum albumin using a multi-spectroscopic method and molecular docking technique. Food Chem. 2015, 173:31-37.
64. Zohoorian-Abootorabi T., Sanee H., Iranfar H., Saberi M.R., Chamani J. Separate and simultaneous binding effects through a non-cooperative behavior between cyclophosphamide hydrochloride and fluoxymesterone upon interaction with human serum albumin: multi-spectroscopic and molecular modeling approaches. Spectrochim. Acta A 2012, 88:177-191.
65. Wen M.G., Zhang X.B., Tian J.N., Ni S.H., Bian H.D., Huang Y.L., Liang H. Binding interaction of xanthoxylin with bovine serum albumin. J. Solution Chem. 2009, 38:391-401.
66. Yeggoni D.P., Rachamallu A., Kallubai M., Subramanyam R. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein. J. Biomol. Struct. Dyn. 2015, 33:1336-1351.
67. Gokara M., Kimavath G.B., Podile A.R., Subramanyam R. Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein. J. Biomol. Struct. Dyn. 2015, 33:196-210.
68. Yeggoni D.P., Subramanyam R. Binding studies of L-3, 4-dihydroxyphenylalanine with human serum albumin. Mol. BioSyst. 2014, 10:3101-3110.
69. Kallubai M., Rachamallu A., Yeggoni D.P., Subramanyam R. Comparative binding mechanism of lupeol compounds with plasma proteins and its pharmacological importance. Mol. BioSyst. 2015, 11:1172-1183.
70. Morrisett J.D., David J.S.K., Pownall H.J., Gotto A.M. Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry 1973, 12:1290-1299.
71. Gokara M., Malavath T., Kalangi S.K., Pallu R., Subramanyam R. Unraveling the binding mechanism of asiatic acid with human serum albumin and its biological implications. J. Biomol. Struct. Dyn. 2014, 32:1290-1302.
72. Neelam S., Gokara M., Sudhamalla B., Amooru D.G., Subramanyam R. Interaction studies of coumaroyltyramine with human serum albumin and its biological importance. J. Phys. Chem. B 2010, 114:3005-3012.
73. Moghaddam M.M., Pirouzi M., Saberi M.R., Chamani J. Comparison of the binding behavior of FCCP with HSA and HTF as determined by spectroscopic and molecular modeling techniques. Luminescence 2014, 29:314-331.